Skip to main content
Loading
Kevin Sill

Kevin Sill, PhD

CEO, Welton Pharma
United States
I’ve held research, clinical development, and leadership roles in the biotechnology industry, with proven success in the development of cancer drugs. Though polymer chemistry is my passion and expertise, I’ve also explored analytical chemistry, polymer physics, nanotechnology, biotechnology and drug delivery applications over the past 20 years. I’ve since co-invented 27 issued US patents, 61 international patents, and co-authored 23 articles in peer-reviewed publications.
Sessions

BIO DOUBLE HELIX SPONSOR

BIO HELIX SPONSOR

CONFERENCE SPONSORS